COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Transcend

Purpose of Study

To demonstrate the safety and efficacy of the SurVeil Drug Coated Balloon for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/ or popliteal arteries

Trial Status

Enrolling

Eligibility Criteria

At least 18 years old, target limb Rutherford classification 2,3, or 4, target lesion must have 70% stenosis

Duration of Participation

Approximately 5 years

Contact Name: Lindsay Risk

Contact Phone: 515-633-3847

Contact Email: lirisk@iowaheart.com